P613: TLR9 SIGNALLING IS A POTENTIAL TUMOUR ESCAPE MECHANISM FOLLOWING BTKI THERAPY FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA. (23rd June 2022) - Kennedy, E.; Mitchell, S.; Burley, T. A.; Liloglou, T.; Johnston, R.; Ashworth, I.; Bak-Blaz, D.; Chamberlain, K.; Ladikou, E.; Mackay, S.; Pepper, C.; Pepper, A. G.